Frankfurt am Main, Germany

Joachim Saas

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 7.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: The Innovative Contributions of Inventor Joachim Saas

Introduction

Joachim Saas, an accomplished inventor based in Frankfurt am Main, Germany, has made significant strides in the field of pharmaceuticals and biotechnology. With a total of two patents to his name, his work focuses on innovative compositions and methodologies aimed at treating various health conditions, particularly related to cartilage and joint diseases.

Latest Patents

Saas’ latest patents showcase his dedication to enhancing medical treatments. The first patent, titled "Expression and folding in the manufacturing process of CD-RAP by using a CD-RAP precursor protein," outlines a groundbreaking approach to producing native CD-RAP, with potential applications in pharmaceuticals for treating cartilage diseases. This invention details a CD-RAP precursor protein composed of specific amino acids that can assist in preventing and treating conditions arising from aggrecan degradation.

The second patent, "N-(4-(azaindazol-6-yl)-phenyl)-sulfonamides and their use as pharmaceuticals," presents a novel class of compounds that modulate protein kinase activity, particularly targeting serum and glucocorticoid regulated kinase (SGK-1). These pharmacologically active compounds are designed for the treatment of degenerative joint disorders and inflammatory conditions such as osteoarthritis and rheumatism, reflecting Saas's commitment to addressing significant medical challenges.

Career Highlights

Throughout his career, Joachim Saas has made meaningful contributions to the pharmaceutical industry. He has held positions in prominent companies such as Sanofi and Bionet Pharma GmbH. His experience in these organizations has equipped him with the knowledge and expertise needed to drive innovative research and development processes aimed at creating effective therapeutic solutions.

Collaborations

Saas has collaborated with talented individuals in the field, including Marc Nazare and Nis Halland. These partnerships have fostered a collaborative environment that promotes the exchange of ideas and expertise, leading to advancements in both research and the development of innovative products.

Conclusion

In summary, Joachim Saas stands out as a noteworthy inventor whose patents reflect significant advancements in the pharmaceutical field. His innovative approaches to treating cartilage and joint diseases highlight the impact of dedicated research and collaboration in enhancing medical treatments. As he continues to push the boundaries of science, the future looks promising for both Saas and the innovations stemming from his work.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…